raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:79095

Congenital bile acid synthesis defect type 4

Synonyms: 2-methylacyl-CoA racemase deficiency · AMACR deficiency · Alpha-methyl-acyl-CoA racemase deficiency · BASD4 · Liver disease-retinitis pigmentosa-polyneuropathy-epilepsy syndrome

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
All ages
Status
active

Congenital bile acid synthesis defect type 4 (BAS defect type 4) is an anomaly of bile acid synthesis characterized by mild cholestatic liver disease, fat malabsorption and/or neurological disease.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCongenital bile acid synthesis defect type 42-methylacyl-CoA racemase deficiency · AMACR deficiency · Alpha-methyl-acyl-CoA racemase deficiency · BASD4 · Liver disease-retinitis pigmentosa-polyneuropathy-epilepsy syndrome
frDéficit congénital de synthèse des acides biliaires type 4DSAB4 · Déficit en 2-méthylacyl-CoA racémase · Déficit en AMACR · Déficit en alpha-méthylacyl-CoA racémase
deGallensäuresynthesedefekt, kongenitaler, Typ 42-Methylacyl-CoA-Racemase-Mangel · AMACR-Mangel · Alpha-Methylacyl-CoA-Racemase-Mangel · BASD4 · Leberkrankheit-Retinitis pigmentosa-Polyneuropathie-Epilepsie-Syndrom
esDefecto congénito de la síntesis de ácidos biliares tipo 4BASD4 · Deficiencia de 2-metilacil-CoA racemasa · Deficiencia de AMACR · Deficiencia de alfa-metilacil-CoA racemasa · Síndrome de enfermedad del hígado-retinosis pigmentaria-polineuropatía-epilepsia
itDifetto congenito della sintesi degli acidi biliari, tipo 4
nlCongenitaal defect van galzuursynthese type 4BASD4 · Deficiëntie van 2-methylacyl-CoA-racemase · Deficiëntie van alfa-methylacyl-CoA-racemase · Leverziekte - retinitis pigmentosa - polyneuropathie - epilepsie-syndroom · AMACR-deficiëntie
ptDefeito congénito da síntese de ácidos biliares tipo 4BASD4 · Deficiência de 2-metilacil-coA racemase · Deficiência de AMACR · Deficiência de alfa-metil-acil-coA racemase · Síndrome de doença hepática-retinite pigmentosa-polineuropatia-epilepsia
plWrodzony defekt syntezy kwasów żółciowych typu 4BASD4 · Niedobór AMACR · Niedobór racemazy 2-metyloacylo-CoA · Niedobór racemazy alfa-metylo-acylo-CoA · Zespół choroby wątroby, barwnikowego zwyrodnienia siatkówki, polineuropatii i padaczka
csVrozená porucha syntézy žlučových kyselin, typ 4Deficit 2-methylacyl-CoA racemázy · Deficit AMACR · Deficit alfa-methyl-acyl-CoA racemázy · Syndrom zahrnující onemocnění jater, retinitis pigmentosa, polyneuropatii a epilepsii
ukВроджений дефект синтезу жовчних кислот, тип 4Дефіцит 2-метилацил-КоА рацемази · Дефіцит альфа-метил-ацил-КоА-рацемази · Дефіцит AMACR · BASD4 · Захворювання печінки-пігментна дегенерація сітківки-полінейропатія-епілептичний синдром
zh先天性胆汁酸合成障碍4型肝病-色素性视网膜炎-多神经病变-癫痫综合征
trDoğumsal safra asidi sentez bozukluğu tip 4BASD4 · AMACR eksikliği · 2-metilasil-CoA rasemaz eksikliği · Alfa-metil-asil-CoA rasemaz eksikliği · Karaciğer hastalığı-retinitis pigmentosa-polinöropati-epilepsi sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM214950Evalidated
OMIM614307BTNTvalidated
ICD-10K76.8NTBTattributedvalidated
ICD-115C52.11NTBTindexvalidated
MONDO0008967Evalidated
MeSHC535444Evalidated
UMLSC3280428Evalidated
GARD10046Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
AMACRDisease-causing germline mutation(s) inAssessedHGNC:451ENSG000002421106044895p13.2alpha-methylacyl-CoA racemase18577977[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families5 casesWorldwideCase(s)Validated10655068[PMID]_12512044[PMID]_ [EXPERT]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

27 annotations · validated 2021-11-26
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0012379Abnormal enzyme/coenzyme activity
Frequent (79-30%)
HP:0001298Encephalopathy
HP:0000580Pigmentary retinopathy
HP:0001250Seizure
HP:0007141Sensorimotor neuropathy
HP:0001328Specific learning disability
Occasional (29-5%)
HP:0001251Ataxia
HP:0000518Cataract
HP:0001081Cholelithiasis
HP:0002611Cholestatic liver disease
HP:0000716Depression
HP:0003236Elevated circulating creatine kinase concentration
HP:0002910Elevated circulating hepatic transaminase concentration
HP:0200084Giant cell hepatitis
HP:0002573Hematochezia
HP:0030516Homonymous hemianopia
HP:0000135Hypogonadism
HP:0011892Low levels of vitamin K
HP:0002354Memory impairment
HP:0001268Mental deterioration
HP:0002076Migraine
HP:0003201Rhabdomyolysis
HP:0100753Schizophrenia
HP:0000763Sensory neuropathy
HP:0002401Stroke-like episode
HP:0001337Tremor
HP:0005978Type II diabetes mellitus

Run the differential on the 1 obligate / very frequent terms

Annotation source: 34267495[PMID]_31951345[PMID]_33047465[PMID]

7

Sources for this card